This federal contract award, identified as SPE2DB24D8002|SPE2DB24FJMUF, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc. The $2,210.83 firm fixed-price delivery order is for the supply of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat diabetes.
Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The company has significant experience providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense through prime contracts and blanket purchase agreements with the DLA Troop Support Medical. This contract is part of the DLA's ECAT Generation V Program, which seeks to procure commercial medical equipment, accessories, consumables, and medical simulation equipment from manufacturers and distributors. The contract has an ultimate completion date of August 22, 2024.
Generated 11/20/24, 9:19 AM